At a glance
ClinicalIndex Comparison RecordN/ACompleted· 58 enrolled
Drug / intervention
NxStage System Onedevice
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.
Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.
Comparison of Nocturnal Hemodialysis (NHD) and Short Daily Hemodialysis (DHD) With the NxStage® System One™
In Brief
A clinical study evaluating NxStage System One for Kidney Failure, Chronic and End-Stage Renal Disease. Completed, enrolled 58 participants across 9 sites.
Detailed Summary
The purpose of this study is to determine whether or not nocturnal hemodialysis is equivalent to short daily hemodialysis on a per treatment basis, using the NxStage System One in the home setting.
Study Details
Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsKidney Failure, Chronic, End-Stage Renal Disease
CountriesUnited States
Collaborators--
Timeline
N/ACompletedFinished
20082009201020112012201320142015201620172018201920202021202220232024202520262027
Enrollment StartApr 2008
First PostedApr 2008
Primary CompletionMay 2014
TodayJul 2026
First PostedApr 28, 2008
Enrollment StartApr 1, 2008
Primary CompletionMay 1, 2014
TodayJul 2, 2026
Enrollment to primary: 6.1 yearsPosted 18.2 years ago
Interventions
NxStage System Onedevice
Comparison of Nocturnal (NHD) and Short Daily Hemodialysis (DHD) with the NxStage System One